Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sclerotherapy With Polidocanol Foam In The Management Of First, Second And Third-Grade Hemorrhoidal Disease In Patients With Bleeding Disorders: A Prospective Cohort Study

NCT04188171 is registered in ClinicalTrials.gov with Universidade do Porto as lead sponsor.

NCT NCT04188171
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04188171 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sclerotherapy With Polidocanol Foam In The Management Of First, Second And Third-Grade Hemorrhoidal Disease In Patients With Bleeding Disorders: A Prospective Cohort Study
Lead sponsor
Universidade do Porto
Phase
Phase 2/3
Overall status
Unknown status
Start date
August 1, 2018
Completion date
February 1, 2021
Enrollment
150 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

bleeding disorder, hemorrhoids